Archives for March 22, 2006

← 2006

Europe's wholesalers show 'zero tolerance' on fake drugs

By  Gregory Roumeliotis

The European Association of Pharmaceutical Full-line Wholesalers (GIRP) has outlined measures it is taking to keep counterfeit medicines out of the legitimate supply chain while urging pharmaceutical manufacturers and pharmacists to do more together...

American lawmakers initiate mercury probe for vaccines

By  Gregory Roumeliotis

The US Congress has asked the country's National Institute of Environmental Health Sciences (NIEHS) to conduct research on the connection between vaccines containing mercury and neurological disorders, further battering public confidence not just in...

In-PharmaTechnologist Excipient GMP Series

The quest for harmonisation

By  Gregory Roumeliotis

Unlike with active pharmaceutical ingredients (APIs), there are no clear governmental good manufacturing practice (GMP) guidelines for excipients in the US, Europe or China. Now the International Pharmaceutical Excipients Council (IPEC) is launching a...

Oxford Biomedica licenses its technology for HIV drug

By  Gregory Roumeliotis

British gene therapy firm Oxford Biomedica has licensed its VSV-G viral envelope technology for gene delivery to American biotech company VIRxSYS which hopes it can use it to successfully produce its promising anti-HIV/AIDS product currently in Phase...

Malvern targets particle size analysis of inhalers

By  Gregory Roumeliotis

Analytical instrumentation supplier Malvern has introduced a new inhalation cell for its Spraytec system for particle size analysis of aerosols and sprays, allowing the rapid characterisation of systems such as dry powder inhalers (DPIs), metered dose...